1. Home
  2. |Insights
  3. |IAM Ranks Crowell & Moring in Patent 1000 2022

IAM Ranks Crowell & Moring in Patent 1000 2022

Firm News | 2 min read | 06.30.22

Washington – June 30, 2022: Intellectual Asset Management recognized Crowell & Moring in its IAM Patent 1000 – The World’s Leading Patent Practitioners guide, awarding the firm a gold band ranking as one of the top four firms handling patent litigation and transactions in Belgium, and a silver ranking for the firm’s Chicago office. This marks the ninth consecutive year that the firm has been ranked in the guide in Belgium. The guide also recommended Brussels partner Kristof Roox in the gold band; partner Jan-Diederik Lindemans in the silver band; and senior counsel Jurgen Figys in the bronze band.

IAM notes that the firm is “the go-to outfit in Belgium for generic pharmaceutical companies [and] provides sterling litigation counsel and receives glowing feedback as a result.”

The guide also quotes a firm client: “Unsurpassed in terms of its satisfaction rate, C&M’s team is extremely knowledgeable, hands-on and sharp. Their approach is professional but not stuffy, and they can effectively build bridges across European countries.”

In Chicago, IAM noted that the combination of Crowell & Moring and Brinks, Gilson & Lione created “a combination and cross-disciplinary approach that is compelling to global leaders in technological innovation.”

IAM Patent 1000 conducts over 1,800 interviews with in-house counsel and other lawyers to gather market intelligence on leading firms and individuals and develop its recognitions. 

To see the firm’s full rankings in the Patent 1000, please visit here.

About Crowell & Moring LLP

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia. Drawing on significant government, business, industry and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex litigation and arbitration, regulatory and policy, and corporate and transactional issues.  The firm is consistently recognized for its commitment to pro bono service and its programs and initiatives to advance diversity, equity and inclusion.  

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....

View All Insights